Literature DB >> 27347409

Effects of the Sijunzi decoction on the immunological function in rats with dextran sulfate-induced ulcerative colitis.

Wangui Yu1, Bing Lu1, Hengwen Zhang2, Yanxiang Zhang3, Jin Yan1.   

Abstract

The present study investigated the effects of the Sijunzi decoction (SJZD) at various dosages on the immunological function of rats with 3% dextran sulfate sodium (DSS; molecular weight 5,000)-induced ulcerative colitis (UC). A total of 40 male Wistar rats were randomly divided into 5 groups: Normal, model, low-dose SJZD, moderate-dose SJZD and high-dose SJZD groups. The 3% DSS was intragastrically administered for 7 consecutive days in order to induce the UC model. The normal group consumed distilled water. Subsequently, SJZD (5.0, 10.0 and 30.0 g/kg) was intragastrically administered, and scores of the disease activity index (DAI) were calculated. After 2 weeks, all the rats were sacrificed. Scores of the colon mucosa damage index (CMDI) were evaluated; and secretory immunoglobulin A (sIgA) and interleukin-2 (IL-2) were measured in intestinal tissue by ELISA assays. The model group rats had ulcers, hyperemia and interstitial edema and infiltrated inflammatory cells. SJZD attenuated the severity of the gross lesions and reduced the histopathological injuries. Compared with the normal group, DAI and CMDI were significantly increased (P<0.01), and levels of determined sIgA in the intestinal mucosa and IL-2 in the intestinal tissue were significantly decreased (P<0.05) in the model group. Compared with the model group, moderate and high doses of SJZD showed a restoration effect on all the aforementioned indexes, and the high dose was the most effective. In conclusion, SJZD can ameliorate inflammation in DSS-induced UC rats. The mechanism is most likely due to enhancing intestinal local immunity.

Entities:  

Keywords:  Sijunzi decoction; interleukin-2; intestinal mucosa immunity; secretory immunoglobulin A; ulcerative colitis

Year:  2016        PMID: 27347409      PMCID: PMC4906636          DOI: 10.3892/br.2016.678

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  23 in total

1.  Changes in the incidence of inflammatory bowel disease: what does it mean?

Authors: 
Journal:  Eur J Intern Med       Date:  2000-08       Impact factor: 4.487

2.  Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.

Authors:  Evgenia Greenbaum; Dan Engelhard; Reuven Levy; Miriam Schlezinger; Avraham Morag; Zichria Zakay-Rones
Journal:  Vaccine       Date:  2004-06-30       Impact factor: 3.641

3.  Assessment of serum IL-1, IL-2 and IFN-γ levels in untreated pulmonary tuberculosis patients: role in pathogenesis.

Authors:  Muralidhar K Katti
Journal:  Arch Med Res       Date:  2011-04       Impact factor: 2.235

4.  Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis.

Authors:  Kathleen J Myers; Sreekant Murthy; Anne Flanigan; Donna R Witchell; Madeline Butler; Susan Murray; Andrew Siwkowski; Deborah Goodfellow; Karen Madsen; Brenda Baker
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

5.  Protection of PC12 cells against superoxide-induced damage by isoflavonoids from Astragalus mongholicus.

Authors:  De-Hong Yu; Yong-Ming Bao; Li-Jia An; Ming Yang
Journal:  Biomed Environ Sci       Date:  2009-02       Impact factor: 3.118

6.  Anti-inflammatory effect of Helichrysum oligocephalum DC extract on acetic acid - Induced acute colitis in rats.

Authors:  Mohsen Minaiyan; Nasrollah Ghassemi-Dehkordi; Parvin Mahzouni; Najme-Sadat Ahmadi
Journal:  Adv Biomed Res       Date:  2014-02-28

7.  Preventive Effect of TU-100 on a Type-2 Model of Colitis in Mice: Possible Involvement of Enhancing Adrenomedullin in Intestinal Epithelial Cells.

Authors:  Atsushi Kaneko; Toru Kono; Naoko Miura; Naoko Tsuchiya; Masahiro Yamamoto
Journal:  Gastroenterol Res Pract       Date:  2013-11-19       Impact factor: 2.260

8.  Si-jun-zi decoction treatment promotes the restoration of intestinal function after obstruction by regulating intestinal homeostasis.

Authors:  Xiangyang Yu; Zhigang Cui; Zhenli Zhou; Tao Shan; Donghua Li; Naiqiang Cui
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-28       Impact factor: 2.629

Review 9.  A review on chemical-induced inflammatory bowel disease models in rodents.

Authors:  Puneet Kaur Randhawa; Kavinder Singh; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2014-08-13       Impact factor: 2.016

Review 10.  Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.

Authors:  Eddy Owaga; Rong-Hong Hsieh; Beatrice Mugendi; Sakhile Masuku; Chun-Kuang Shih; Jung-Su Chang
Journal:  Int J Mol Sci       Date:  2015-09-01       Impact factor: 5.923

View more
  6 in total

1.  Periplaneta americana extract ameliorates dextran sulfate sodium-induced ulcerative colitis via immunoregulatory and PI3K/AKT/NF-κB signaling pathways.

Authors:  Lianli Ni; Qian Lu; Miao Tang; Lu Tao; Hairong Zhao; Chenggui Zhang; Yun Yu; Xiumei Wu; Heng Liu; Ri Cui
Journal:  Inflammopharmacology       Date:  2022-03-18       Impact factor: 4.473

2.  Effects of Jianpi Qingchang decoction on the quality of life of patients with ulcerative colitis: A randomized controlled trial.

Authors:  Yan-Cheng Dai; Lie Zheng; Ya-Li Zhang; Xuan Chen; De-Liang Chen; Zhi-Peng Tang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

3.  Clinical efficacy and safety of modified Sijunzi decoction for the treatment of ulcerative colitis: A protocol for a systematic review and meta-analysis.

Authors:  Shu Wei Tian; Yan Ling Zhang; Bin Wang; Ji Ping Liu; Chuan Wang; Juan Zhang
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

Review 4.  Chinese Classical Formula Sijunzi Decoction and Chronic Atrophic Gastritis: Evidence for Treatment Approach?

Authors:  Danan Gan; Aili Xu; Hongbo Du; Yong'an Ye
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-24       Impact factor: 2.629

5.  Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials.

Authors:  Yi-Ming Chen; Jie-Min Deng; Yi Wen; Bin Chen; Jiang-Tao Hou; Bin Peng; Shi-Jing Zhang; Hong Mi; Qi-Long Jiang; Xia-Lin Wu; Feng-Bin Liu; Xin-Lin Chen
Journal:  Trials       Date:  2020-05-12       Impact factor: 2.279

6.  Enhancement of neuroprotective activity of Sagunja-tang by fermentation with lactobacillus strains.

Authors:  Nam-Hui Yim; Min Jung Gu; Hee Ra Park; Youn-Hwan Hwang; Jin Yeul Ma
Journal:  BMC Complement Altern Med       Date:  2018-11-28       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.